Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion type Assertion NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_head.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion description "[GSTM1 and GSTT1 null genotypes were found to be associated with an increased risk of drug eruption (OR 2.27, 95% CI 1.20-5.21; OR 2.48, 95% CI 1.12-6.39, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_provenance.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion evidence source_evidence_literature NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_provenance.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion SIO_000772 14740231 NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_provenance.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion wasDerivedFrom befree-20140225 NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_provenance.
- NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_assertion wasGeneratedBy ECO_0000203 NP628245.RAyj58FbLGiy-p_Ln-NFCZYrgl0T8ZvHUMUMi-d1otfyI130_provenance.